Truthout
Health Care

One-Man Show “Mercy Killers” Reveals Dark Side of Health Care System
With 60 percent of bankruptcies caused by medical bills, performer Michael Milligan joins the host to discuss his new play “Mercy Killers.”

|
Are We Getting Enough Bang for Our Health Care Buck? Hardly
The US healthcare system costs each of us about twice as much as those in other wealthy countries.

Obamacare Subsidies on the Line
Dean Baker and Jeremy Holden discuss two federal courts decisions which could disqualify lower and middle income earners for subsidies and the forces working to dismantle Obamacare.

Advocates Mourn the Passing of Anna Conte, a Child at the Center of New York’s Battle for Medical Marijuana
Death fuels demand for emergency access to medical marijuana for critically ill patients in New York.

|
The Good News About Obamacare in the June Jobs Report
The issue of voluntary part-time relates to Obamacare because one of the main purposes was to allow people to get insurance outside of employment.

|
The Poisoners and Their Accomplices
“Poison Spring: The Secret History of Pollution and the EPA” takes up where Rachel Carson left off - and the news is not good.

Shouldn’t We Pay Nannies and People Who Care for Our Parents a Living Wage?
A recent US Supreme Court ruling weakening the unions of state-funded workers limits the ability of many domestic workers who care for our most vulnerable to win higher pay, …

|
Maternal Deaths Due to HIV a Grim Reality
From Jun. 30 to Jul. 1, 800 health experts, officials and activists will gather in Johannesburg, South Africa, at the third Partners' Forum around the Action Plan for Women's …

Supreme Court Backs Hobby Lobby – and Corporate Personhood
The Supreme Court ruled Monday that the government may not require certain businesses to provide their employees with health insurance that covers contraception which offends the owner's religious beliefs.

|
Will India Be the Uber of the Pharmaceutical Industry?
If the Indian drug industry makes the patent system unviable, we may finally adopt a 21st century system for financing the development of new drugs.